Integrated ABC/VEN-analysis of medicinal prescribing in pharmacotherapy of bronchial asthma in children

Authors

  • I. A. Kostiuk Bogomolets National Medical University, Kyiv, Ukraine,
  • K. L. Kosiachenko Bogomolets National Medical University, Kyiv, Ukraine,

DOI:

https://doi.org/10.14739/2409-2932.2019.2.171074

Keywords:

ABC/VEN-analysis, medical prescriptions, bronchial asthma in children

Abstract

 

Nowadays, medical institutions pay great attention to optimizing the medicine provision of inpatients. A significant range of medicines, which are registered in Ukraine and are used for the treatment of bronchial asthma (BA) in children, require improving the system of their selection for a particular department in conditions of optimal use of limited funds.

Aim. The aim of the work is to assess the expense rationality of BA pharmacotherapy in children by the results of ABC/VEN-analysis.

Materials and methods. Retrospective analysis of historical data of medical records in patients with the main diagnosis of BA, ABC/VEN-analysis.

Results. For the economic evaluation of the rational medicine usage, an ABC-analysis was performed, which made it possible to rank medical prescriptions by level of consumption. Group A (80 % of costs) was formed by 14 international non-proprietary names (INN) (11.2 % of the total INN number), Group B (15 % of costs) – 25 INN (25.2 %), and Group C (5 % of the cost) – 61 INN (63.6 %). Formal VEN-analysis revealed the ratio of indices for INN, trade names and the number of medical prescriptions, which were 3:27:41; 11:74:102 and 411:768:618 respectively. It was established that during 2018 the largest part of group A expenditure was occupied by the segment of essential medicine (54.7 %), and vital – only 17.9 %, which indicates the need to further optimize the drug supply for children with asthma.

Conclusions. The results of the conducted research demonstrate the need to improve the medicine provision of children with asthma, and can be used to make management decisions, purchase medicine by healthcare institutions and reduce the cost of pharmacotherapy by increasing the share of domestic medicine.

References

(2013) Nakaz MOZ Ukrainy «Pro zatverdzhennia ta vprovadzhennia medyko-tehnolohichnykh dokumentiv zi standartyzatsii medychnoi dopomohy pry bronhialnii astmi» vid 08.10.2013 r. №868 [Order of the Ministry of Health of Ukraine «About the hardening of the medical and technological documents for the standardization of medical aid for bronchial asthma» from October 8, 2013, №868]. Retrieved from https://zakon.rada.gov.ua/rada/show/v0868282-13 [in Ukrainian].

(1992) Zakon Ukrainy «Osnovy zakonodavstva Ukrainy pro okhoronu zdorovia» vid 19.11.1992 r. №2801-XII [Law of Ukraine «On the basis of the legislation of Ukraine on the protection of health» from November 19, 1992, №2801-XII]. Retrieved from https://zakon.rada.gov.ua/laws/show/2801-12. [in Ukrainian].

(2010) Nakaz MOZ Ukrainy «Pro zatverdzhennia Kontseptsii rozvytku farmatsevtychnoho sektoru haluzi okhorony zdorovia Ukrainy na 2011–2020 roky» vid 13.09.2010 r. №769 [Order of the Ministry of Health of Ukraine «About the hardening of the Concept of the development of a pharmaceutical sector for the health of Ukraine for 2011–2020» from September 13, 2010, №769]. Retrieved from https://zakon.rada.gov.ua/rada/show/v0769282-10. [in Ukrainian].

Makarenko, O. V. & Kryvoviaz, O. V. (2016). Rezultaty kompleksnoho ABC/VEN/chastotnoho analizu zastosuvannia preparativ hrupy S01E «Protyhlaukomni zasoby ta miotyky» za pokaznykamy vytratnosti, zhyttevoi neobkhidnosti ta chastoty pryznachen [Results of complex ABC / VEN / frequency analysis application of S01E preparations «Anti-mechanical means and myotics» on performance indicators, life needs and frequencies of appointments]. Scientific Journal «ScienceRise: Pharmaceutical Science», 4, 9–13. [in Ukrainian]. doi: 10.15587/2519-4852.2016.85906

Masheiko, A. M., Makarenko, O. V., & Mavrutenkov, V. V. (2016). Kliniko-ekonomichnyi analiz vytrat na farmakoterapiiu hostroho tonzylitu v umovakh statsionaru [Сlinical economic analysis of the financial costs for the pharmacotherapy of acute tonsillitis in the conditions of the hospital]. Farmatsevtychnyi chasopys, 4, 48–53. [in Ukrainian]. doi: 10.11603/2312-0967.2016.4.7121

Nemchenko, A. S. & Balynska, M. V. (2016). Rezultaty kliniko-ekonomichnoho analizu spozhyvannia likarskykh preparativ khvorym dytiachoho viku na virusnu diareiu [Results of clinical and economic analysis consumption drugs off patients childhood with viral diarrhea]. Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, 3, 60–67. [in Ukrainian].

Tkachova, O. V. & Silayev, A. O. Kliniko-ekonomichnyi analiz farmakoterapii ditei z hostrym nazofarynitom [Сlinical and economic analysis of pharmacotherapy of children with acute nasopharyngitis]. Sotsialna farmatsiia v okhoroni zdorovia, 3, 75–82. [in Ukrainian].

(2009) Postanova Kabinetu Ministriv Ukrainy «Pro deiaki pytannia derzhavnoho rehuliuvannia tsin na likarski zasoby ta vyroby medychnoho pryznachennia: pryiniatyi» vid 25.03.2009 r. №333 [Resolution of the Cabinet of Ministers of Ukraine «On some issues of state regulation of prices for medicines and medical products» from March 25 2009, №333]. Retrieved from https://zakon.rada.gov.ua/laws/show/333-2009-p [in Ukrainian].

Natsionalnyi perelik osnovnykh likarskykh zasobiv [National List of Essential Medicines]. Retrieved from https://www.natsperelik.com.ua/ [in Ukrainian].

(2018) Nakaz MOZ Ukrainy «Pro zatverdzhennia desiatoho vypusku Derzhavnoho formuliara likarskykh zasobiv ta zabezpechennia yoho dostupnosti» vid 10.05.2018 r. №868 [Order of the Ministry of Health of Ukraine «On approval of the tenth issue of the State Form of Medicines and ensuring its availability» May 10, 2018, №868]. Retrieved from http://moz.gov.ua/uploads/1/5052-dn_20180510_868_dod_2.pdf. [in Ukrainian].

Downloads

How to Cite

1.
Kostiuk IA, Kosiachenko KL. Integrated ABC/VEN-analysis of medicinal prescribing in pharmacotherapy of bronchial asthma in children. Current issues in pharmacy and medicine: science and practice [Internet]. 2019Jun.24 [cited 2024Nov.22];(2). Available from: http://pharmed.zsmu.edu.ua/article/view/171074

Issue

No. 2 (2019)

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.     Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)